Skip to main content
. Author manuscript; available in PMC: 2015 Feb 9.
Published in final edited form as: BJU Int. 2014 Jun;113(6):871–877. doi: 10.1111/bju.12450

Figure 3.

Figure 3

Pretreatment (A, C, E) and post-treatment (B, D, F) computed tomographic scans from selected patients. Patient 3 received cetuximab alone. Patients 9 and 17 received cetuximab plus cisplatin. Time between scans was six months (A, B), six weeks (C, D), and four months (E, F). Arrows indicate metastatic tumors.